New research reporting guideline helps compare multiple treatments

July 29, 2015

How do the dozens of available hypertension drugs stack up against each other? What about anti-depressants? And anti-bleeding drugs? These are just a few of the important questions that Dr. Brian Hutton and his colleagues are answering through network meta-analysis – a relatively new kind of study that allows researchers to mathematically combine the results of many clinical trials of different treatments. And now, Dr. Hutton, Dr. David Moher and others are helping to advance the field as a whole with the publication of the PRISMA extension statement for network meta-analyses in Annals of Internal Medicine. As described in a supporting editorial, this “much-anticipated” guideline “will bring consistency, clarity and transparency to the reporting of evidence from networks of trials that present the benefits and harms among competing interventions.”

About The Ottawa Hospital

The Ottawa Hospital is one of Canada’s largest learning and research hospitals with over 1,100 beds, approximately 12,000 staff and an annual budget of over $1.2 billion. Our focus on research and learning helps us develop new and innovative ways to treat patients and improve care. As a multi-campus hospital, affiliated with the University of Ottawa, we deliver specialized care to the Eastern Ontario region, but our techniques and research discoveries are adopted around the world. We engage the community at all levels to support our vision for better patient care.

For further information, please contact

Lois Ross
Senior Communications Specialist
Ottawa Hospital Research Institute
Office: 613-737-8899 x73687
Cell: 613-297-8315

Tags: Journalology